Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V L Cohan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|January 15, 1989
Induction of histamine release from human skin mast cells by bradykinin analogsI D Lawrence, J A Warner, V L Cohan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacologyW A Massey, C B Guo, A M Dvorak, et al.
The American Journal of Physiology|June 1, 1996
Production and characterization of guinea pig IL-5 in baculovirus-infected insect cellsM Mansour, M Karmilowicz, S J Hawrylik, et al.
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biochemical Pharmacology|January 15, 1989
Induction of histamine release from human skin mast cells by bradykinin analogsI D Lawrence, J A Warner, V L Cohan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacologyW A Massey, C B Guo, A M Dvorak, et al.
The American Journal of Physiology|June 1, 1996
Production and characterization of guinea pig IL-5 in baculovirus-infected insect cellsM Mansour, M Karmilowicz, S J Hawrylik, et al.
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Pageof 2